Controlled Substance Monitoring and Drugs of Abuse Testing
JH · Effective Oct 1, 2015
21 active Medicare policies list R56.01, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Jan 22, 2023
JM · Effective Jan 22, 2023
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
4 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of R56.01 |
|---|---|---|
| Ambulatory Electroencephalography | Jun 8, 2023 | Covered |
| Attended Electroencephalographic (EEG) Video Monitoring | Apr 28, 2023 | Covered |
| Genetic Testing | Feb 27, 2024 | Covered |
| Policy | Effective | Status of R56.01 |
|---|---|---|
| Electroencephalography | Feb 15, 2026 | Covered |
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Mar 13, 2017
JF · Effective Mar 13, 2017
JL · Effective Oct 1, 2024
National · Effective Oct 1, 2025
National · Effective Oct 1, 2025
JL · Effective Jan 1, 2026
National · Effective Oct 23, 2025
JL · Effective Jan 1, 2026
National · Effective Oct 16, 2025